Mettler-Toledo International, Inc. MTD
- Market cap
- $30.4B
- P/E
- 33.9×
Follow MTD
Mettler-Toledo International, Inc. (MTD) P/B ratio
As of 25 September 2026, Mettler-Toledo International, Inc. (MTD) trades at a P/B ratio of 2,372×. Over the past ten years it has ranged from 0.0× (June 2026) to 4,251× (August 2022); the current reading is higher than 98% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 1,326× | 479.10% |
| FY2021 | 229× | 137.83% |
| FY2020 | 96.3× | 107.89% |
| FY2019 | 46.3× | 91.63% |
| FY2018 | 24.2× | (17.84%) |
| FY2017 | 29.4× | 14.24% |
| FY2016 | 25.8× | 59.22% |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2,005× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| WAT Waters Corporation compare | 2.8× |
| LH Labcorp Holdings Inc. compare | 2.9× |
| DGX Quest Diagnostics Incorporated compare | 3.4× |
| A Agilent Technologies, Inc. compare | 6.6× |
| IQV IQVIA Holdings Inc. compare | 7.1× |
| ILMN Illumina, Inc. compare | 14.5× |
| IDXX IDEXX Laboratories, Inc. compare | 25.4× |
| MTD Mettler-Toledo International, Inc. | 2,372× |
| Diagnostics & Research industry median | 3.1× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on MTD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement